Zura Bio Limited Revenue and Competitors
Estimated Revenue & Valuation
- Zura Bio Limited's estimated annual revenue is currently $4.3M per year.
- Zura Bio Limited's estimated revenue per employee is $94,348
Employee Data
- Zura Bio Limited has 46 Employees.
- Zura Bio Limited grew their employee count by 44% last year.
Zura Bio Limited's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Chief Technology Officer | Reveal Email/Phone |
4 | Chief Legal Officer | Reveal Email/Phone |
5 | EVP, Chief Operating Officer, Chief Legal Officer and Corporate Secretary | Reveal Email/Phone |
6 | VP, Finance and Accounting | Reveal Email/Phone |
7 | Head People and Culture | Reveal Email/Phone |
8 | Head Portfolio Management and Clinical Operations | Reveal Email/Phone |
9 | SVP, Legal | Reveal Email/Phone |
10 | Executive Director, Clinical Development | Reveal Email/Phone |
Zura Bio Limited Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Zura Bio Limited?
Zura Bio Limited is a clinical-stage biotechnology company advancing immunology assets into Phase 2 development programs, including ZB-168 and torudokimab. ZB-168 is an anti IL7R α inhibitor that has the potential to impact diseases driven by IL7 and TSLP biological pathways. Zura aims to develop a portfolio of therapeutic indications for ZB-168 which build on existing Phase 1b data in Type 1 Diabetes demonstrating a favorable safety profile and strong biological rationale. Torudokimab is a fully human, high affinity monoclonal antibody that neutralizes IL33 and is currently at the Phase 2 clinical development stage. Zura Bio is headquartered in San Diego, CA with team members in the UK and USA.
keywords:N/AN/A
Total Funding
46
Number of Employees
$4.3M
Revenue (est)
44%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.2M | 46 | 35% | N/A |
#2 | $11.4M | 46 | N/A | N/A |
#3 | $5.3M | 46 | N/A | N/A |
#4 | $5.3M | 46 | -4% | N/A |
#5 | $9.9M | 46 | 18% | N/A |